You are here : Home > BIG > New clinical application of soluble VE-cadherin: Rheumatoid arthritis

Highlight | Autoimmune diseases

New clinical application of soluble VE-cadherin: Rheumatoid arthritis


​​​​​​Rheumatoid arthritis is a very common autoimmune disease, characterized by an exacerbated inflammatory response at the joints and by increased cardiovascular risk. Rheumatologists do not yet have a predictive marker to prevent atherosclerosis associated with this pathology. The BCI laboratory researchers have shown that the blood test VE-cadherin (a protein that ensures the cohesion of endothelial cells of blood vessel walls) is a promising candidate.​

Published on 1 August 2012

​​ 

Top page